Conference Coverage

Urology groups endorse two prostate biopsy approaches


 

AT AUA 2023

Lack of training

The AUA said another reason it did not endorse the transperineal approach was that currently, American urologists lack training and experience with transperineal procedures.

Dr. Grummet blamed major medical centers for any gap in the familiarity of clinicians with transperineal biopsies, which have been available for more than a decade.

“It is incumbent on the leaders of urology departments globally to ensure that their colleagues are trained in transperineal biopsy and have access to the appropriate equipment,” he said in an interview. “Lack of training didn’t seem to prevent the rapid uptake of robotic prostatectomy – a far more complex procedure.”

The authors have disclosed no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Prostate cancer drug shortage leaves some with uncertainty
MDedge Hematology and Oncology
Survival improved for some patients with metastatic cancers
MDedge Hematology and Oncology
Guidelines for assessing cancer risk may need updating
MDedge Hematology and Oncology
Panel backs limited new olaparib use in prostate cancer
MDedge Hematology and Oncology
Prostate biopsies a laughing (gas) matter?
MDedge Hematology and Oncology
Cancer pain declines with cannabis use
MDedge Hematology and Oncology
Expert discusses which diets are best, based on the evidence
MDedge Hematology and Oncology
Study shows higher obesity-related cancer mortality in areas with more fast food
MDedge Hematology and Oncology
Number of cancer survivors with functional limitations doubled in 20 years
MDedge Hematology and Oncology
Limit PSA screening to men with symptoms
MDedge Hematology and Oncology